{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T22:40:03Z","timestamp":1749940803230,"version":"3.41.0"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:p>Baclofen and \u03b3-hydroxybutyrate (GHB) exert \u03b3-aminobutyric acid (GABA)<jats:sub>B<\/jats:sub> receptor agonism and have therapeutic utility but possess different pharmacological activities. We examined whether separate groups of mice could be trained to discriminate either baclofen or GHB, and the contribution of GABA<jats:sub>B<\/jats:sub> receptors to discriminative stimulus effects. Male C57BL\/6J mice were trained to discriminate either baclofen (3.2 mg\/kg, intraperitoneal) or GHB (178 mg\/kg, intraperitoneal) from saline under a fixed-ratio 10 schedule. The GABA<jats:sub>B<\/jats:sub> antagonist 3-aminopropyl(diethoxymethyl)phosphinic acid (CGP 35348) was used to pharmacologically assess GABA<jats:sub>B<\/jats:sub> receptor involvement. The selectivity of the resulting discriminations was assessed with the opioid agonist morphine and the benzodiazepine midazolam. In baclofen-trained mice, both baclofen and GHB were readily discriminated. Baclofen produced a maximum of 86% baclofen-appropriate responding. CGP 35348 (320 mg\/kg, i.p.) produced a 4.7-fold rightward shift in the dose-effect function. GHB produced a maximum of 85.8% baclofen-appropriate responding. In GHB-trained mice, both GHB and baclofen were readily discriminated. In GHB-trained mice, GHB produced a maximum of 85.3% drug-appropriate responding; CGP 35348 (320 mg\/kg, i.p.) produced a 1.8-fold rightward shift in the GHB discrimination dose-effect function. Baclofen produced up to 70.0% GHB-appropriate responding. CGP 35348 (320 mg\/kg, i.p.) significantly antagonized baclofen discrimination and baclofen produced up to 37% GHB-appropriate responding up to doses that disrupted operant responding. Morphine did not produce substitution for either baclofen or GHB. Midazolam produced partial substitution for both. GHB and baclofen discrimination assays in mice provide a useful approach for examining different receptor types mediating the effects of these two drugs.<\/jats:p>","DOI":"10.1097\/fbp.0000000000000691","type":"journal-article","created":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T15:33:03Z","timestamp":1660145583000},"page":"427-434","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["The discriminative stimulus effects of baclofen and gamma hydroxybutyrate in C57BL\/6J mice"],"prefix":"10.1097","volume":"33","author":[{"given":"Jenny L.","family":"Wilkerson","sequence":"first","affiliation":[{"name":"Department of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takato","family":"Hiranita","sequence":"additional","affiliation":[{"name":"Department of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wouter","family":"Koek","sequence":"additional","affiliation":[{"name":"Pharmacology"},{"name":"Psychiatry, University of Texas Health Science Center, San Antonio, Texas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lance R.","family":"McMahon","sequence":"additional","affiliation":[{"name":"Department of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, Florida"},{"name":"Pharmacology"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,8,3]]},"reference":[{"key":"R1-20250614","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1517\/13543780902905855","article-title":"The therapeutic potential of gamma-hydroxybutyric acid for alcohol dependence: balancing the risks and benefits. A focus on clinical data.","volume":"18","author":"Addolorato","year":"2009","journal-title":"Expert Opin Investig Drugs"},{"key":"R2-20250614","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.bcp.2013.10.028","article-title":"GHB receptor targets in the CNS: focus on high-affinity binding sites.","volume":"87","author":"Bay","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"R3-20250614","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.smrv.2011.09.001","article-title":"Narcolepsy and effectiveness of gamma-hydroxybutyrate (GHB): a systematic review and meta-analysis of randomized controlled trials.","volume":"16","author":"Boscolo-Berto","year":"2012","journal-title":"Sleep Med Rev"},{"key":"R4-20250614","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2009.04.012","article-title":"Illicit gamma-hydroxybutyrate (GHB) and pharmaceutical sodium oxybate (Xyrem): differences in characteristics and misuse.","volume":"104","author":"Carter","year":"2009","journal-title":"Drug Alcohol Depend"},{"key":"R5-20250614","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1124\/jpet.104.077578","article-title":"Novel gamma-hydroxybutyric acid (GHB) analogs share some, but not all, of the behavioral effects of GHB and GABAB receptor agonists.","volume":"313","author":"Carter","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"R6-20250614","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jpainsymman.2004.05.002","article-title":"Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: a systematic review.","volume":"28","author":"Chou","year":"2004","journal-title":"J Pain Symptom Manage"},{"key":"R7-20250614","doi-asserted-by":"crossref","first-page":"e79062","DOI":"10.1371\/journal.pone.0079062","article-title":"\u03b3-hydroxybutyric acid (GHB) is not an agonist of extrasynaptic GABAA receptors.","volume":"8","author":"Connelly","year":"2013","journal-title":"PLoS One"},{"key":"R8-20250614","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s00213-005-0276-0","article-title":"Effects of combining ethanol (EtOH) with gamma-hydroxybutyrate (GHB) on the discriminative stimulus, locomotor, and motor-impairing functions of GHB in mice.","volume":"185","author":"Cook","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"R9-20250614","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00213-013-3037-5","article-title":"Multiple nicotine training doses in mice as a basis for differentiating the effects of smoking cessation aids.","volume":"228","author":"Cunningham","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"key":"R10-20250614","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2147\/JPR.S124526","article-title":"Differential drug effects on spontaneous and evoked pain behavior in a model of trigeminal neuropathic pain.","volume":"10","author":"Deseure","year":"2017","journal-title":"J Pain Res"},{"key":"R11-20250614","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/syn.10238","article-title":"Baclofen antagonizes nicotine-, cocaine-, and morphine-induced dopamine release in the nucleus accumbens of rat.","volume":"50","author":"Fadda","year":"2003","journal-title":"Synapse"},{"key":"R12-20250614","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1021\/jm00017a016","article-title":"Phosphinic acid analogues of GABA: 2. Selective, orally active GABAB antagonists.","volume":"38","author":"Froestl","year":"1995","journal-title":"J Med Chem"},{"key":"R13-20250614","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1744-9081-8-20","article-title":"The \u03b3-aminobutyric acid type B (GABAB) receptor agonist baclofen inhibits morphine sensitization by decreasing the dopamine level in rat nucleus accumbens.","volume":"8","author":"Fu","year":"2012","journal-title":"Behav Brain Funct"},{"key":"R14-20250614","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/0269881105049041","article-title":"Gamma hydroxy butyrate abuse and dependency.","volume":"19","author":"Gonzalez","year":"2005","journal-title":"J Psychopharmacol"},{"key":"R15-20250614","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s00213-005-2165-y","article-title":"Involvement of gamma-hydroxybutyrate (GHB) and GABA-B receptors in the acute behavioral effects of GHB in baboons.","volume":"180","author":"Goodwin","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"R17-20250614","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1111\/j.1460-9568.2003.03013.x","article-title":"Specific gamma-hydroxybutyrate-binding sites but loss of pharmacological effects of gamma-hydroxybutyrate in GABA(B)(1)-deficient mice.","volume":"18","author":"Kaupmann","year":"2003","journal-title":"Eur J Neurosci"},{"key":"R18-20250614","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1523\/JNEUROSCI.12-07-02623.1992","article-title":"Regulation of somatodendritic dopamine release in the ventral tegmental area by opioids and GABA: an in vivo microdialysis study.","volume":"12","author":"Klitenick","year":"1992","journal-title":"J Neurosci"},{"key":"R19-20250614","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1124\/jpet.105.096909","article-title":"Discriminative stimulus effects of gamma-hydroxybutyrate: role of training dose.","volume":"317","author":"Koek","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"R20-20250614","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1124\/jpet.112.202226","article-title":"Discriminative stimulus effects of the GABAB receptor-positive modulator rac-BHFF: comparison with GABAB receptor agonists and drugs of abuse.","volume":"344","author":"Koek","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"R21-20250614","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1124\/jpet.103.056093","article-title":"Discriminative stimulus effects of gamma-hydroxybutyrate in pigeons: role of diazepam-sensitive and -insensitive GABA(A) and GABA(B) receptors.","volume":"308","author":"Koek","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"R22-20250614","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00213-008-1160-5","article-title":"Cataleptic effects of gamma-hydroxybutyrate (GHB) and baclofen in mice: mediation by GABA(B) receptors, but differential enhancement by N-methyl-d-aspartate (NMDA) receptor antagonists.","volume":"199","author":"Koek","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"R23-20250614","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00213-007-0718-y","article-title":"Cataleptic effects of gamma-hydroxybutyrate (GHB), its precursor gamma-butyrolactone (GBL), and GABAB receptor agonists in mice: differential antagonism by the GABAB receptor antagonist CGP35348.","volume":"192","author":"Koek","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"key":"R24-20250614","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0028-3908(64)90074-7","article-title":"Sodium 4-hydroxybutyrate.","volume":"3","author":"Laborit","year":"1964","journal-title":"Int J Neuropharmacol"},{"key":"R25-20250614","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0301-0082(96)00064-0","article-title":"The gamma-hydroxybutyrate signalling system in brain: organization and functional implications.","volume":"51","author":"Maitre","year":"1997","journal-title":"Prog Neurobiol"},{"key":"R26-20250614","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/bjp.2008.135","article-title":"Characterization of (R,S)-5,7-di-tert-butyl-3-hydroxy-3-trifluoromethyl-3H-benzofuran-2-one as a positive allosteric modulator of GABAB receptors.","volume":"154","author":"Malherbe","year":"2008","journal-title":"Br J Pharmacol"},{"key":"R27-20250614","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00213-013-3204-8","article-title":"Effect of baclofen on morphine-induced conditioned place preference, extinction, and stress-induced reinstatement in chronically stressed mice.","volume":"231","author":"Meng","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"key":"R28-20250614","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.neuroscience.2009.05.017","article-title":"gamma-Hydroxybutyrate (GHB) induces GABA(B) receptor independent intracellular Ca2+ transients in astrocytes, but has no effect on GHB or GABA(B) receptors of medium spiny neurons in the nucleus accumbens.","volume":"162","author":"Moln\u00e1r","year":"2009","journal-title":"Neuroscience"},{"key":"R29-20250614","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/syn.21886","article-title":"Baclofen prevents the elevated plus maze behavior and BDNF expression during naloxone precipitated morphine withdrawal in male and female mice.","volume":"70","author":"Pedr\u00f3n","year":"2016","journal-title":"Synapse"},{"key":"R30-20250614","first-page":"158","article-title":"The role of GABAB receptors in morphine self-administration.","volume":"4","author":"Ramshini","year":"2013","journal-title":"Int J Prev Med"},{"key":"R31-20250614","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1097\/00001756-200207020-00007","article-title":"Baclofen decreases methamphetamine self-administration in rats.","volume":"13","author":"Ranaldi","year":"2002","journal-title":"Neuroreport"},{"key":"R32-20250614","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1016\/0006-2952(70)90087-0","article-title":"Formation and regional distribution of gamma-hydroxybutyric acid in mammalian brain.","volume":"19","author":"Roth","year":"1970","journal-title":"Biochem Pharmacol"},{"key":"R33-20250614","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1007\/s00415-007-0566-z","article-title":"Intrathecal baclofen and morphine in multiple sclerosis patients with severe pain and spasticity.","volume":"254","author":"Sadiq","year":"2007","journal-title":"J Neurol"},{"key":"R34-20250614","doi-asserted-by":"crossref","first-page":"349","DOI":"10.33549\/physiolres.933008","article-title":"Baclofen reversed thermal place preference in rats with chronic constriction injury.","volume":"65","author":"Salte","year":"2016","journal-title":"Physiol Res"},{"key":"R35-20250614","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/978-3-540-69248-5_11","article-title":"Recognising nicotine: the neurobiological basis of nicotine discrimination.","author":"Smith","year":"2009","journal-title":"Handb Exp Pharmacol"},{"key":"R36-20250614","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.neuropharm.2005.06.009","article-title":"Effect of a selective GABA(B) receptor agonist baclofen on the mu-opioid receptor agonist-induced antinociceptive, emetic and rewarding effects.","volume":"49","author":"Suzuki","year":"2005","journal-title":"Neuropharmacology"},{"key":"R38-20250614","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000477548","article-title":"Effects of injection of gamma-aminobutyric acid agonists into the nucleus accumbens on naloxone-induced morphine withdrawal.","volume":"100","author":"Topkara","year":"2017","journal-title":"Pharmacology"},{"key":"R39-20250614","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.drugalcdep.2009.03.004","article-title":"Sedative and hypothermic effects of gamma-hydroxybutyrate (GHB) in rats alone and in combination with other drugs: assessment using biotelemetry.","volume":"103","author":"van Nieuwenhuijzen","year":"2009","journal-title":"Drug Alcohol Depend"},{"key":"R40-20250614","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/S0022-3565(24)35044-X","article-title":"Baclofen inhibits heroin self-administration behavior and mesolimbic dopamine release.","volume":"290","author":"Xi","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"R41-20250614","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.neuropharm.2016.04.028","article-title":"The positive allosteric GABAB receptor modulator rac-BHFF enhances baclofen-mediated analgesia in neuropathic mice.","volume":"108","author":"Zemoura","year":"2016","journal-title":"Neuropharmacology"}],"container-title":["Behavioural Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FBP.0000000000000691","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T22:00:16Z","timestamp":1749938416000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FBP.0000000000000691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,3]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/fbp.0000000000000691","relation":{},"ISSN":["0955-8810"],"issn-type":[{"type":"print","value":"0955-8810"}],"subject":[],"published":{"date-parts":[[2022,8,3]]}}}